Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...

With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

Novo Nordisk has announced it is ending its distribution collaboration with US telehealth firm Hims & Hers Health over the ...

Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat ... full three-month observation period, even though weight loss was modest and statistically non-significant.” ...